Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerald P Radich

Showing results (51-60 of 208) with videos related to

Pageof 21
Sort By:
BMC Genomics|August 24, 2021
A graphical, interactive and GPU-enabled workflow to process long-read sequencing dataShishir Reddy, Ling-Hong Hung, Olga Sala-Torra, et al.
Blood|August 6, 2009
The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray dataVivian G Oehler, Ka Yee Yeung, Yongjae E Choi, et al.
American Journal of Hematology|October 1, 2010
Comprehensive evaluation of time-to-response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: which parameter at which time-point does matter?Dong Hwan ' Dennis ' Kim, Lakshmi Sriharsha, Chul Won Jung, et al.
Blood Cancer Journal|April 23, 2023
Management of chronic myeloid leukemia in 2023 - common ground and common senseJayastu Senapati, Koji Sasaki, Ghayas C Issa, et al.
Experimental Hematology|September 4, 2004
Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8Uwe Platzbecker, Peter Kurre, Philippe Guardiola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemiaKim Robien, Cornelia M Ulrich, Jeannette Bigler, et al.
British Journal of Haematology|December 29, 2007
Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?Derek L Stirewalt, Andrew J Mhyre, Mario Marcondes, et al.
Scientific Reports|April 7, 2016
Combined Population Dynamics and Entropy Modelling Supports Patient Stratification in Chronic Myeloid LeukemiaMarc Brehme, Steffen Koschmieder, Maryam Montazeri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2003
Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemiaSoheil Meshinchi, Wendy M Leisenring, Paul A Carpenter, et al.
British Journal of Haematology|February 27, 2004
Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemiaDerek L Stirewalt, Soheil Meshinchi, Steven J Kussick, et al.
Pageof 21

Showing results (51-60 of 208) with videos related to

Sort By:
Pageof 21
BMC Genomics|August 24, 2021
A graphical, interactive and GPU-enabled workflow to process long-read sequencing dataShishir Reddy, Ling-Hong Hung, Olga Sala-Torra, et al.
Blood|August 6, 2009
The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray dataVivian G Oehler, Ka Yee Yeung, Yongjae E Choi, et al.
American Journal of Hematology|October 1, 2010
Comprehensive evaluation of time-to-response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: which parameter at which time-point does matter?Dong Hwan ' Dennis ' Kim, Lakshmi Sriharsha, Chul Won Jung, et al.
Blood Cancer Journal|April 23, 2023
Management of chronic myeloid leukemia in 2023 - common ground and common senseJayastu Senapati, Koji Sasaki, Ghayas C Issa, et al.
Experimental Hematology|September 4, 2004
Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8Uwe Platzbecker, Peter Kurre, Philippe Guardiola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemiaKim Robien, Cornelia M Ulrich, Jeannette Bigler, et al.
British Journal of Haematology|December 29, 2007
Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?Derek L Stirewalt, Andrew J Mhyre, Mario Marcondes, et al.
Scientific Reports|April 7, 2016
Combined Population Dynamics and Entropy Modelling Supports Patient Stratification in Chronic Myeloid LeukemiaMarc Brehme, Steffen Koschmieder, Maryam Montazeri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2003
Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemiaSoheil Meshinchi, Wendy M Leisenring, Paul A Carpenter, et al.
British Journal of Haematology|February 27, 2004
Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemiaDerek L Stirewalt, Soheil Meshinchi, Steven J Kussick, et al.
Pageof 21